IMA vs WFC · rev $9.2M vs P/E 15, $272.05B cap
ImageneBio, Inc. (IMA) versus Wells Fargo & Company (WFC) — a side-by-side from cached financials, not a winner call.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Wells Fargo & Company (WFC) is a banks - diversified company listed on US. It is led by Charlie Scharf.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
WFC does not have a complete income-statement cache yet.
IMA currently screens at market cap $64.7M. WFC currently screens at market cap $272.05B and trailing P/E 15.0.
Not investment advice. Open the IMA and WFC stock pages for the full models.
Not investment advice.